Washington, D.C., approved a fiscal 2027 budget that would shift about $7.8 million in opioid settlement money — including $2.3 million for the city’s Medicaid contribution and at least $5.5 million for addiction treatment centers — to cover costs previously paid from the general fund. For clinicians, that means nearly 9,800 residents, including 3,500 receiving medication-assisted treatment for opioid addiction, may keep access to existing services, but without the net expansion in care many settlement agreements were meant to finance.

The Move

• D.C.’s fiscal 2027 budget uses opioid settlement dollars to backfill recurring health spending rather than clearly adding new treatment capacity.

• Budget documents show roughly $2.3 million would help pay the district’s Medicaid share, while at least $5.5 million would support treatment centers previously funded through the general budget.

• The D.C. Department of Behavioral Health says the council passed a legally certified budget and that the money supports 17 community-based providers.

Why It Matters for Care

• In the short term, the funding may preserve continuity for addiction services that reached nearly 9,800 residents last year, including 3,500 in medication-assisted treatment.

• At the bedside, the key issue is capacity: if settlement dollars replace existing appropriations instead of supplementing them, clinicians may see fewer new slots, slower service expansion, and less flexibility to respond to overdose trends.

• That could particularly affect harm reduction, low-barrier treatment access, and other interventions designed for a more dangerous and unpredictable drug supply.

Between the Lines

• The fight is really about supplantation: advocates and the district’s Opioid Abatement Advisory Commission argue the city is using one-time legal settlement money to plug structural budget pressure.

• Critics say that may conflict with D.C. law requiring opioid abatement funds to supplement, not supplant, existing spending.

• Political pressure is coming from multiple directions, including recovery advocates, Councilmember Christina Henderson, and Attorney General Brian Schwalb, who questioned whether some uses were authorized.

What to Watch

• Whether the Department of Behavioral Health publicly explains the legal rationale for using $2.3 million in settlement funds for the city’s Medicaid contribution.

• Whether congressional review of the D.C. budget triggers any delay or change, though that process is typically the final step rather than a policy rewrite.

• Whether D.C. revises future opioid spending plans toward new programs and expanded services, or whether other jurisdictions adopt similar backfilling strategies as fiscal pressure grows.

Source: KFF Health News